Clinical  ||| S:0 E:9 ||| JJ
analysis  ||| S:9 E:18 ||| NN
of  ||| S:18 E:21 ||| IN
126  ||| S:21 E:25 ||| CD
cases  ||| S:25 E:31 ||| NNS
of  ||| S:31 E:34 ||| IN
severe  ||| S:34 E:41 ||| JJ
precocious  ||| S:41 E:52 ||| NNS
preeclampsia  ||| S:52 E:65 ||| VBP
complicated  ||| S:65 E:77 ||| VBN
with  ||| S:77 E:82 ||| IN
fetal  ||| S:82 E:88 ||| JJ
growth  ||| S:88 E:95 ||| NN
retardation  ||| S:95 E:107 ||| NN
To  ||| S:107 E:110 ||| TO
explore  ||| S:110 E:118 ||| VB
the  ||| S:118 E:122 ||| DT
clinical  ||| S:122 E:131 ||| JJ
characteristics  ||| S:131 E:147 ||| NNS
and  ||| S:147 E:151 ||| CC
maternal  ||| S:151 E:160 ||| NNS
and  ||| S:160 E:164 ||| CC
infant  ||| S:164 E:171 ||| JJ
prognosis  ||| S:171 E:181 ||| NN
of  ||| S:181 E:184 ||| IN
severe  ||| S:184 E:191 ||| JJ
precocious  ||| S:191 E:202 ||| NNS
preeclampsia  ||| S:202 E:215 ||| VBP
complicated  ||| S:215 E:227 ||| VBN
with  ||| S:227 E:232 ||| IN
fetal  ||| S:232 E:238 ||| JJ
growth  ||| S:238 E:245 ||| NN
retardation ||| S:245 E:256 ||| NN
.  ||| S:256 E:258 ||| .
A  ||| S:258 E:260 ||| DT
study  ||| S:260 E:266 ||| NN
was  ||| S:266 E:270 ||| VBD
conducted  ||| S:270 E:280 ||| VBN
for  ||| S:280 E:284 ||| IN
126  ||| S:284 E:288 ||| CD
patients  ||| S:288 E:297 ||| NNS
with  ||| S:297 E:302 ||| IN
early  ||| S:302 E:308 ||| JJ
onset  ||| S:308 E:314 ||| JJ
severe  ||| S:314 E:321 ||| JJ
preeclampsia ||| S:321 E:333 ||| NN
.  ||| S:333 E:335 ||| .
According  ||| S:335 E:345 ||| VBG
to  ||| S:345 E:348 ||| TO
the  ||| S:348 E:352 ||| DT
gestational  ||| S:352 E:364 ||| JJ
week  ||| S:364 E:369 ||| NN
( ||| S:369 E:370 ||| -LRB-
GW ||| S:370 E:372 ||| NNP
)  ||| S:372 E:374 ||| -RRB-
of  ||| S:374 E:377 ||| IN
morbility ||| S:377 E:386 ||| NN
,  ||| S:386 E:388 ||| ,
they  ||| S:388 E:393 ||| PRP
were  ||| S:393 E:398 ||| VBD
divided  ||| S:398 E:406 ||| VBN
into  ||| S:406 E:411 ||| IN
group  ||| S:411 E:417 ||| NN
A  ||| S:417 E:419 ||| DT
( ||| S:419 E:420 ||| -LRB-
GW  ||| S:420 E:422 ||| NNP
< ||| S:422 E:423 ||| SYM
28 ||| S:423 E:425 ||| CD
,  ||| S:425 E:427 ||| ,
n  ||| S:427 E:429 ||| VBG
=  ||| S:429 E:431 ||| SYM
36 ||| S:431 E:433 ||| CD
) ||| S:433 E:434 ||| -RRB-
,  ||| S:434 E:436 ||| ,
group  ||| S:436 E:442 ||| NN
B  ||| S:442 E:444 ||| NNP
( ||| S:444 E:445 ||| -LRB-
28  ||| S:445 E:448 ||| CD
≤  ||| S:448 E:450 ||| CD
GW  ||| S:450 E:452 ||| CD
< ||| S:452 E:453 ||| SYM
32 ||| S:453 E:455 ||| CD
,  ||| S:455 E:457 ||| ,
n  ||| S:457 E:459 ||| VBG
=  ||| S:459 E:461 ||| SYM
40 ||| S:461 E:463 ||| CD
)  ||| S:463 E:465 ||| -RRB-
and  ||| S:465 E:469 ||| CC
group  ||| S:469 E:475 ||| NN
C  ||| S:475 E:477 ||| NNP
( ||| S:477 E:478 ||| -LRB-
32  ||| S:478 E:481 ||| CD
≤  ||| S:481 E:483 ||| CD
GW  ||| S:483 E:485 ||| CD
< ||| S:485 E:486 ||| SYM
34 ||| S:486 E:488 ||| CD
,  ||| S:488 E:490 ||| ,
n  ||| S:490 E:492 ||| VBG
=  ||| S:492 E:494 ||| SYM
50 ||| S:494 E:496 ||| CD
) ||| S:496 E:497 ||| -RRB-
.  ||| S:497 E:499 ||| .
And  ||| S:499 E:503 ||| CC
then  ||| S:503 E:508 ||| RB
compare  ||| S:508 E:516 ||| VB
the  ||| S:516 E:520 ||| DT
respective  ||| S:520 E:531 ||| JJ
clinical  ||| S:531 E:540 ||| JJ
characteristics  ||| S:540 E:556 ||| NNS
and  ||| S:556 E:560 ||| CC
the  ||| S:560 E:564 ||| DT
result  ||| S:564 E:571 ||| NN
of  ||| S:571 E:574 ||| IN
mother  ||| S:574 E:581 ||| NN
and  ||| S:581 E:585 ||| CC
infant ||| S:585 E:591 ||| NN
.  ||| S:591 E:593 ||| .
At  ||| S:593 E:596 ||| IN
admission ||| S:596 E:605 ||| NN
,  ||| S:605 E:607 ||| ,
no  ||| S:607 E:610 ||| DT
statistical  ||| S:610 E:622 ||| JJ
difference  ||| S:622 E:633 ||| NN
existed  ||| S:633 E:641 ||| VBD
among  ||| S:641 E:647 ||| IN
3  ||| S:647 E:649 ||| CD
groups  ||| S:649 E:656 ||| NNS
in  ||| S:656 E:659 ||| IN
blood  ||| S:659 E:665 ||| NN
pressure ||| S:665 E:673 ||| NN
,  ||| S:673 E:675 ||| ,
blood  ||| S:675 E:681 ||| NN
platelets ||| S:681 E:690 ||| NN
,  ||| S:690 E:692 ||| ,
24  ||| S:692 E:695 ||| CD
h  ||| S:695 E:697 ||| CD
urine  ||| S:697 E:703 ||| JJ
protein  ||| S:703 E:711 ||| NN
quantity ||| S:711 E:719 ||| NN
,  ||| S:719 E:721 ||| ,
urea  ||| S:721 E:726 ||| JJ
nitrogen ||| S:726 E:734 ||| NN
,  ||| S:734 E:736 ||| ,
D-2  ||| S:736 E:740 ||| CD
polymer  ||| S:740 E:748 ||| NNS
or  ||| S:748 E:751 ||| CC
serum  ||| S:751 E:757 ||| JJ
creatinine  ||| S:757 E:768 ||| NNS
( ||| S:768 E:769 ||| -LRB-
P  ||| S:769 E:771 ||| NNP
>  ||| S:771 E:773 ||| CD
0.05 ||| S:773 E:777 ||| CD
) ||| S:777 E:778 ||| -RRB-
.the  ||| S:778 E:783 ||| CD
rate  ||| S:783 E:788 ||| NN
of  ||| S:788 E:791 ||| IN
complication  ||| S:791 E:804 ||| NN
declined  ||| S:804 E:813 ||| VBD
with  ||| S:813 E:818 ||| IN
advancing  ||| S:818 E:828 ||| VBG
gestational  ||| S:828 E:840 ||| JJ
weeks  ||| S:840 E:846 ||| NNS
of  ||| S:846 E:849 ||| IN
morbility  ||| S:849 E:859 ||| NN
in  ||| S:859 E:862 ||| IN
all  ||| S:862 E:866 ||| DT
three  ||| S:866 E:872 ||| CD
groups ||| S:872 E:878 ||| NNS
.  ||| S:878 E:880 ||| .
And  ||| S:880 E:884 ||| CC
the  ||| S:884 E:888 ||| DT
composition  ||| S:888 E:900 ||| NN
of  ||| S:900 E:903 ||| IN
complication  ||| S:903 E:916 ||| NN
indicated  ||| S:916 E:926 ||| VBD
no  ||| S:926 E:929 ||| DT
statistical  ||| S:929 E:941 ||| JJ
difference  ||| S:941 E:952 ||| NN
( ||| S:952 E:953 ||| -LRB-
P  ||| S:953 E:955 ||| NNP
>  ||| S:955 E:957 ||| CD
0.05 ||| S:957 E:961 ||| CD
) ||| S:961 E:962 ||| -RRB-
;  ||| S:962 E:964 ||| :
there  ||| S:964 E:970 ||| EX
existed  ||| S:970 E:978 ||| VBD
statistical  ||| S:978 E:990 ||| JJ
difference  ||| S:990 E:1001 ||| NN
in  ||| S:1001 E:1004 ||| IN
asphyxia  ||| S:1004 E:1013 ||| JJ
neonatorum  ||| S:1013 E:1024 ||| NN
and  ||| S:1024 E:1028 ||| CC
perinatal  ||| S:1028 E:1038 ||| JJ
mortality  ||| S:1038 E:1048 ||| NN
rates  ||| S:1048 E:1054 ||| NNS
between  ||| S:1054 E:1062 ||| IN
any  ||| S:1062 E:1066 ||| DT
two  ||| S:1066 E:1070 ||| CD
of  ||| S:1070 E:1073 ||| IN
three  ||| S:1073 E:1079 ||| CD
groups  ||| S:1079 E:1086 ||| NNS
( ||| S:1086 E:1087 ||| -LRB-
P  ||| S:1087 E:1089 ||| NNP
< ||| S:1089 E:1091 ||| SYM
0.05  ||| S:1091 E:1096 ||| CD
for  ||| S:1096 E:1100 ||| IN
all ||| S:1100 E:1103 ||| DT
) ||| S:1103 E:1104 ||| -RRB-
.  ||| S:1104 E:1106 ||| .
Comparing  ||| S:1106 E:1116 ||| VBG
expectant  ||| S:1116 E:1126 ||| JJ
treatment  ||| S:1126 E:1136 ||| NN
time  ||| S:1136 E:1141 ||| NN
and  ||| S:1141 E:1145 ||| CC
delivery  ||| S:1145 E:1154 ||| NN
method  ||| S:1154 E:1161 ||| NN
of  ||| S:1161 E:1164 ||| IN
three  ||| S:1164 E:1170 ||| CD
groups ||| S:1170 E:1176 ||| NNS
,  ||| S:1176 E:1178 ||| ,
the  ||| S:1178 E:1182 ||| DT
expectant  ||| S:1182 E:1192 ||| JJ
time  ||| S:1192 E:1197 ||| NN
of  ||| S:1197 E:1200 ||| IN
Group  ||| S:1200 E:1206 ||| NNP
B  ||| S:1206 E:1208 ||| NNP
was  ||| S:1208 E:1212 ||| VBD
obviously  ||| S:1212 E:1222 ||| RB
longer  ||| S:1222 E:1229 ||| RBR
than  ||| S:1229 E:1234 ||| IN
those  ||| S:1234 E:1240 ||| DT
of  ||| S:1240 E:1243 ||| IN
the  ||| S:1243 E:1247 ||| DT
other  ||| S:1247 E:1253 ||| JJ
two ||| S:1253 E:1256 ||| CD
,  ||| S:1256 E:1258 ||| ,
both  ||| S:1258 E:1263 ||| DT
indicated  ||| S:1263 E:1273 ||| JJ
statistical  ||| S:1273 E:1285 ||| JJ
difference  ||| S:1285 E:1296 ||| NN
( ||| S:1296 E:1297 ||| -LRB-
P  ||| S:1297 E:1299 ||| NNP
< ||| S:1299 E:1301 ||| SYM
0.05 ||| S:1301 E:1305 ||| CD
) ||| S:1305 E:1306 ||| -RRB-
.  ||| S:1306 E:1308 ||| .
However ||| S:1308 E:1315 ||| RB
,  ||| S:1315 E:1317 ||| ,
the  ||| S:1317 E:1321 ||| DT
difference  ||| S:1321 E:1332 ||| NN
had  ||| S:1332 E:1336 ||| VBD
no  ||| S:1336 E:1339 ||| DT
statistical  ||| S:1339 E:1351 ||| JJ
significance  ||| S:1351 E:1364 ||| NN
between  ||| S:1364 E:1372 ||| IN
groups  ||| S:1372 E:1379 ||| NNS
A  ||| S:1379 E:1381 ||| DT
and  ||| S:1381 E:1385 ||| CC
C  ||| S:1385 E:1387 ||| NNP
( ||| S:1387 E:1388 ||| -LRB-
P  ||| S:1388 E:1390 ||| NNP
>  ||| S:1390 E:1392 ||| CD
0.05 ||| S:1392 E:1396 ||| CD
) ||| S:1396 E:1397 ||| -RRB-
.  ||| S:1397 E:1399 ||| .
And  ||| S:1399 E:1403 ||| CC
uterine-incision  ||| S:1403 E:1420 ||| JJ
delivery  ||| S:1420 E:1429 ||| NN
was  ||| S:1429 E:1433 ||| VBD
the  ||| S:1433 E:1437 ||| DT
major  ||| S:1437 E:1443 ||| JJ
delivery  ||| S:1443 E:1452 ||| NN
mode  ||| S:1452 E:1457 ||| NN
among  ||| S:1457 E:1463 ||| IN
all  ||| S:1463 E:1467 ||| DT
three  ||| S:1467 E:1473 ||| CD
groups ||| S:1473 E:1479 ||| NNS
.  ||| S:1479 E:1481 ||| .
The  ||| S:1481 E:1485 ||| DT
rates  ||| S:1485 E:1491 ||| NNS
of  ||| S:1491 E:1494 ||| IN
asphyxia  ||| S:1494 E:1503 ||| JJ
neonatorum  ||| S:1503 E:1514 ||| NN
and  ||| S:1514 E:1518 ||| CC
perinatal  ||| S:1518 E:1528 ||| JJ
mortality  ||| S:1528 E:1538 ||| NN
decline  ||| S:1538 E:1546 ||| NN
with  ||| S:1546 E:1551 ||| IN
advancing  ||| S:1551 E:1561 ||| VBG
gestational  ||| S:1561 E:1573 ||| JJ
weeks  ||| S:1573 E:1579 ||| NNS
of  ||| S:1579 E:1582 ||| IN
morbility  ||| S:1582 E:1592 ||| NN
in  ||| S:1592 E:1595 ||| IN
cases  ||| S:1595 E:1601 ||| NNS
of  ||| S:1601 E:1604 ||| IN
severe  ||| S:1604 E:1611 ||| JJ
precocious  ||| S:1611 E:1622 ||| NNS
preeclampsia  ||| S:1622 E:1635 ||| VBP
complicated  ||| S:1635 E:1647 ||| VBN
with  ||| S:1647 E:1652 ||| IN
fetal  ||| S:1652 E:1658 ||| JJ
growth  ||| S:1658 E:1665 ||| NN
retardation ||| S:1665 E:1676 ||| NN
.  ||| S:1676 E:1678 ||| .
Therefore ||| S:1678 E:1687 ||| RB
,  ||| S:1687 E:1689 ||| ,
for  ||| S:1689 E:1693 ||| IN
reducing  ||| S:1693 E:1702 ||| VBG
the  ||| S:1702 E:1706 ||| DT
perinatal  ||| S:1706 E:1716 ||| JJ
mortality  ||| S:1716 E:1726 ||| NN
rate ||| S:1726 E:1730 ||| NN
,  ||| S:1730 E:1732 ||| ,
proper  ||| S:1732 E:1739 ||| JJ
measures  ||| S:1739 E:1748 ||| NNS
include  ||| S:1748 E:1756 ||| VBP
early  ||| S:1756 E:1762 ||| JJ
diagnosis ||| S:1762 E:1771 ||| NN
,  ||| S:1771 E:1773 ||| ,
active  ||| S:1773 E:1780 ||| JJ
treatment ||| S:1780 E:1789 ||| NN
,  ||| S:1789 E:1791 ||| ,
close  ||| S:1791 E:1797 ||| JJ
supervision  ||| S:1797 E:1809 ||| NN
of  ||| S:1809 E:1812 ||| IN
mother  ||| S:1812 E:1819 ||| NN
and  ||| S:1819 E:1823 ||| CC
fetal  ||| S:1823 E:1829 ||| JJ
conditions  ||| S:1829 E:1840 ||| NNS
and  ||| S:1840 E:1844 ||| CC
termination  ||| S:1844 E:1856 ||| NN
of  ||| S:1856 E:1859 ||| IN
gestation  ||| S:1859 E:1869 ||| NN
when  ||| S:1869 E:1874 ||| WRB
necessary ||| S:1874 E:1883 ||| JJ
.  ||| S:1883 E:1885 ||| .
